Manufacturing and Production

Showing 15 posts of 5860 posts found.

Purdue Pharma votes for bankruptcy plan to pay for its role in US opioid crisis

July 27, 2021 Manufacturing and Production

Oxycontin makers Purdue Pharma have voted in favour of its bankruptcy reorganisation plan that will provide billions of dollars to …
cdc-un8tv9pw2ik-unsplash_1

Two shots of Pfizer or AstraZeneca vaccine are effective against Delta variant

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …
roche__tree

Roche discussing potential Alzheimer’s treatment with FDA

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roche is discussing its potential treatment, gantenerumab, for Alzheimer’s disease with the FDA as clinical trials proceed. Chief Executive Severin …

NICE approves treatment for rare bile duct cancer

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma). Pemigatinib, …
catalent

$100 million expansion planned for Catalent’s Italian vaccine plant

July 21, 2021 Manufacturing and Production, Research and Development

Contract drug manufacturer, Catalent, has announced its $100 million expansion plans for its site in Agnani, Italy, where it is …
andrei_r_-_shutterstock_1935537274_720

Bial and Medis to enter partnership on CNS treatments

July 20, 2021 Manufacturing and Production, Sales and Marketing

BIAL and Medis have entered into an exclusive partnership on two of Bial’s proprietary drugs: its Parkinson’s treatment Ongentys (opicapone) …

60% of UK COVID-19 hospital admissions are unvaccinated people

July 20, 2021 Manufacturing and Production

The Government’s Chief Scientific Adviser Sir Patrick Vallance has said that 60% of people being admitted to hospital with COVID-19 …

$26 billion opioid settlement to be unveiled this week in US

July 20, 2021 Manufacturing and Production, Research and Development, Sales and Marketing

US state attorneys general are set to unveil a $26 billion settlement this week, aimed at three major drug distributors …

Blood biomarker discovered that can predict COVID-19 infection

July 20, 2021 Manufacturing and Production, Research and Development COVID-19. blood testing, biomarker, gene

Researchers have identified a gene, IFI27, that becomes activated in early stages of COVID-19 even when symptoms are absent, helping …

Brits unable to order lateral flow tests on ‘Freedom Day’

July 20, 2021 Manufacturing and Production

Brits were temporarily unable to order lateral flow COVID-19 test kits on ‘Freedom Day’, the day nearly all restrictions in …

New warning added to J&J vaccine in US

July 13, 2021 Manufacturing and Production COVID-19, FDA, J&J, JJ, US, Vaccine

The FDA has made the decision to add a warning to the fact sheet for Johnson & Johnson’s COVID-19 vaccine, …

Scientists develop pain-free ‘holy grail’ sugar test for diabetics

July 13, 2021 Manufacturing and Production

Scientists in Australia have developed a non-invasive strip that checks glucose levels through saliva that they say is the ‘holy …

Spanner in the works for Sputnik V as missing data reported

July 13, 2021 Manufacturing and Production COVID-19, EMA, Russia, Vaccine

Developers of Russia’s Sputnik V COVID-19 vaccine have repeatedly failed to present data to regulators, Reuters has reported. Five sources …

Scotland approves three new medicines

July 13, 2021 Manufacturing and Production

The SMC has approved three new medicines; atezolizumab to treat adult patients with advanced hepatocellular carcinoma (HCC, a type of …
biogen_austria_238

Biogen announces collaboration on novel MS treatment

July 13, 2021 Manufacturing and Production multiple sclerosis

Biogen and InnoCare Pharma have announced a license and collaboration agreement for orelabrutinib, an oral small molecule Bruton’s tyrosine kinase …
The Gateway to Local Adoption Series

Latest content